Is that what Sustainable Earning stands for?: China Pharma Holdings Inc (CPHI)

Kevin Freeman

China Pharma Holdings Inc [CPHI] stock is trading at $1.36, up 0.37%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CPHI shares have gain 11.98% over the last week, with a monthly amount drifted -22.13%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

China Pharma Holdings Inc [AMEX: CPHI] stock has seen the most recent analyst activity on January 08, 2010, when Rodman & Renshaw initiated its Mkt Outperform rating and assigned the stock a price target of $6.

China Pharma Holdings Inc [CPHI] stock has fluctuated between $1.18 and $3.18 over the past year. China Pharma Holdings Inc [AMEX: CPHI] shares were valued at $1.36 at the most recent close of the market.

Analyzing the CPHI fundamentals

China Pharma Holdings Inc [AMEX:CPHI] reported sales of 4.05M for the trailing twelve months, which represents a drop of -31.26%. Gross Profit Margin for this corporation currently stands at -0.12% with Operating Profit Margin at -0.67%, Pretax Profit Margin comes in at -0.69%, and Net Profit Margin reading is -0.69%. To continue investigating profitability, this company’s Return on Assets is posted at -57063.99, Equity is -113408.71 and Total Capital is -89082.83. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.53.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1733 points at the first support level, and at 0.9917 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6333, and for the 2nd resistance point, it is at 1.9117.

Ratios To Look Out For

For context, China Pharma Holdings Inc’s Current Ratio is 0.35. As well, the Quick Ratio is 0.10, while the Cash Ratio is 0.12. Considering the valuation of this stock, the price to sales ratio is 1.68, the price to book ratio is 0.80.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.